Related Experiment Video
Updated: May 10, 2026
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Cardioprotective functions of HDLs
Kerry-Anne Rye1, Philip J Barter
1Lipid Research Group, Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia 2052.
Journal of Lipid Research
|July 2, 2013
Summary
High density lipoprotein (HDL) cholesterol levels predict cardiovascular risk. Understanding HDL subpopulations is crucial for developing effective therapies to prevent heart disease.
Area of Science:
- Cardiovascular Science
- Lipid Metabolism
- Proteomics
Background:
- High density lipoprotein (HDL) cholesterol is an established inverse predictor of cardiovascular events.
- HDLs possess multiple cardioprotective functions, including cholesterol efflux and anti-inflammatory properties.
Purpose of the Study:
- To review the current understanding of HDL subpopulations and their relationship to cardioprotective functions.
- To identify knowledge gaps regarding the functional roles of different HDL subpopulations.
Main Methods:
- Literature review of human population studies and HDL biology.
- Analysis of existing data on HDL composition, function, and therapeutic interventions.
Main Results:
- HDL is heterogeneous, comprising various subpopulations with largely unknown functions.
- Therapies targeting HDL cholesterol concentration may differentially affect HDL subpopulations.
Conclusions:
- Understanding the contribution of HDL subpopulations to cardioprotection is vital.
- Further research is needed to elucidate the specific roles of HDL subpopulations in cardiovascular health.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...